TARIS BIOMEDICAL

taris-biomedical-logo

TARIS Biomedical develops new therapies designed for the treatment of difficult-to-treat bladder diseases. The company's system is designed to continuously release drugs in the bladder over weeks to months and is deployed and retrieved using minimally-invasive, in-office procedures, enabling drug release to be tailored to match the needs of each disease.

#SimilarOrganizations #People #Financial #Website #More

TARIS BIOMEDICAL

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical Therapeutics

Founded:
2008-01-01

Address:
Lexington, Massachusetts, United States

Country:
United States

Website Url:
http://www.tarisbiomedical.com

Total Employee:
11+

Status:
Active

Contact:
+1 781 676 7750

Email Addresses:
info@TARISbio.com

Total Funding:
113.09 M USD

Technology used in webpage:
SPF Amazon Amazon Virginia Region


Similar Organizations

aclaris-therapeutics-logo

Aclaris Therapeutics

Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.

amicus-therapeutics-logo

Amicus Therapeutics

Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.

evrys-bio-logo

Evrys Bio

Evrys Bio is a pharmaceutical company for providing health care solutions to defend against the virus.

livwell-logo

LivWell

LivWell is dispensary company that provides exceptional cannabis products.

molecular-templates-logo

Molecular Templates

Molecular Templates develops novel therapeutic compounds for cancer.

recro-pharma-logo

Recro Pharma

Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.

scout-bio-logo

Scout Bio

Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.

silver-creek-pharmaceuticals-logo

Silver Creek Pharmaceuticals

Silver Creek Pharmaceuticals is a biotechnology company, develops protein therapeutics to treat cardiovascular diseases.

vintabio-logo

VintaBio

VintaBio is a life sciences company that offers cell and gene therapy manufacturing services.

xeris-pharmaceuticals-logo

Xeris Pharmaceuticals

Xeris Pharmaceuticals is a pharmaceutical company that develops therapies for patients in endocrinology, neurology, and gastroenterology.


Current Advisors List

dennis-ausiello_image

Dennis Ausiello Member of the Board of Directors @ TARIS Biomedical
Board_member

cary-pfeffer_image

Cary Pfeffer Board Member @ TARIS Biomedical
Board_member

kevin-finney_image

Kevin Finney Board Member @ TARIS Biomedical
Board_member

kevin-bitterman_image

Kevin Bitterman Board of Directors @ TARIS Biomedical
Board_member
2008-01-01

jeff-bussgang_image

Jeff Bussgang Member of the Board of Directors @ TARIS Biomedical
Board_member
2014-01-01

edwin-kania_image

Edwin Kania Member of the Board of Directors @ TARIS Biomedical
Board_member

Current Employees Featured

michael-cima_image

Michael Cima
Michael Cima Director @ TARIS Biomedical
Director
2008-01-01

christopher-j-searcy_image

Christopher J. Searcy
Christopher J. Searcy Chief Medical Officer @ TARIS Biomedical
Chief Medical Officer

not_available_image

Robert S. Langer
Robert S. Langer Director @ TARIS Biomedical
Director

dennis-h-giesing_image

Dennis H. Giesing
Dennis H. Giesing Chief Scientific Officer @ TARIS Biomedical
Chief Scientific Officer
2008-11-01

Founder


paul-janssen_image

Paul Janssen

Investors List

roman-abramovich_image

Roman Abramovich

Roman Abramovich investment in Series B - TARIS Biomedical

millhouse-capital_image

Millhouse

Millhouse investment in Series B - TARIS Biomedical

flagship-ventures_image

Flagship Pioneering

Flagship Pioneering investment in Series B - TARIS Biomedical

polaris-partners_image

Polaris Partners

Polaris Partners investment in Series B - TARIS Biomedical

bristol-myers-squibb_image

Bristol-Myers Squibb

Bristol-Myers Squibb investment in Series B - TARIS Biomedical

yongyong-investment_image

Yonghua Capital

Yonghua Capital investment in Series B - TARIS Biomedical

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Series B - TARIS Biomedical

yonjin-venture_image

Yonjin Venture

Yonjin Venture investment in Series A - TARIS Biomedical

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Venture Round - TARIS Biomedical

flagship-ventures_image

Flagship Pioneering

Flagship Pioneering investment in Venture Round - TARIS Biomedical

Official Site Inspections

http://www.tarisbiomedical.com

  • Host name: a6033b2998aeb1ff7.awsglobalaccelerator.com
  • IP address: 99.83.186.106
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "TARIS Biomedical"

TARIS Biomedical - Crunchbase Company Profile

TARIS Biomedical develops new therapies designed for the treatment of difficult-to-treat bladder diseases. The company's system is designed to continuously release drugs in the bladder over weeks to months and is deployed and …See details»

Taris Biomedical - VentureRadar

TARIS Biomedical LLC was formed as part of the transaction between TARIS Biomedical, Inc., and Allergan in August 2014. This new entity retained the management team, pipeline …See details»

Taris Biomedical LLC Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Taris Biomedical LLC of Lexington, MA. Get the latest business insights from Dun & Bradstreet.See details»

Taris Biomedical (US) - PitchBook

Apr 2, 2013 Taris Biomedical (US) General Information Description. Developer of targeted new therapies designed for the treatment of difficult-to-treat bladder diseases. The company's …See details»

Taris Biomedical - Company Profile - Tracxn

Nov 15, 2024 Taris Biomedical - Drug delivery device for bladder diseases. Acquired by Johnson & Johnson. Raised a total funding of $109M over 6 rounds from 8 investors. Founded by …See details»

TARIS Biomedical - Flagship Pioneering

TARIS Biomedical® was founded in 2008 in response to a long-standing clinical need for a convenient, safe, and effective way to treat bladder disease locally. Encouraged by the …See details»

TARIS Biomedical - Overview, News & Similar companies - ZoomInfo

Dec 20, 2019 Johnson & Johnson (NYSE: JNJ) acquired Taris Biomedical, a privately-owned biotechnology company specializing in the development of a novel drug delivery …See details»

TARIS Biomedical - Org Chart, Teams, Culture & Jobs - The Org

TARIS Biomedical is a leader in the local sustained delivery of therapeutics to the genitourinary system. Industries. Pharmaceutical. Headquarters. Lexington, United States. Stage. Series B. …See details»

TARIS Biomedical Company Profile - Office Locations ... - Craft

TARIS Biomedical was founded in 2008 in response to a long-standing clinical need for a convenient, safe, and effective way to treat bladder disease locally. Encouraged by the …See details»

Johnson & Johnson acquires TARIS Biomedical - 2019-12-20

Dec 20, 2019 TARIS Biomedical TARIS Biomedical is a pharmaceutical company developing therapies for genitourinary system issues. Acquiring Organization: Johnson & Johnson …See details»

TARIS Biomedical - Company Profile & Staff Directory - ContactOut

TARIS Biomedical a specialty pharmaceutical company with deep domain expertise in therapeutics and drug-delivery, is focused on local minimally-invasive drug-device …See details»

Taris Biomedical - PitchBook

Taris Biomedical is headquartered in Woburn, MA. What is the size of Taris Biomedical? Taris Biomedical has 8 total employees. What industry is Taris Biomedical in? Taris Biomedical’s …See details»

TARIS Biomedical - Contacts, Employees, Board Members

Organization. TARIS Biomedical . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... About. TARIS Biomedical has 4 current employee profiles, …See details»

TARIS Biomedical | Scientist.com

TARIS Biomedical® is a product-focused drug delivery company treating genitourinary conditions with deep domain expertise in the local delivery and sustained release of therapeutics to target …See details»

Johnson & Johnson Acquires TARIS Biomedical with Focus on …

NEW BRUNSWICK, N.J., Dec. 20, 2019 /PRNewswire/ -- Johnson & Johnson announced today the acquisition of TARIS Biomedical LLC (TARIS), a privately-owned biotechnology company …See details»

TARIS Biomedical® Raises $32 Million and… | Flagship Pioneering

Oct 27, 2015 LEXINGTON, Mass.--(BUSINESS WIRE)--TARIS Biomedical LLC, a company using proprietary delivery technology and deep expertise in bladder biology to develop novel …See details»

Johnson & Johnson Acquires TARIS Biomedical ... - Flagship …

NEW BRUNSWICK, NJ, December 20, 2019 – Johnson & Johnson announced today the acquisition of TARIS Biomedical LLC (TARIS), a privately-owned biotechnology company …See details»

TARIS - Janssen

2 days ago A small pretzel-shaped device designed as a novel approach for the treatment of bladder cancer attracted Janssen Oncology to TARIS Biomedical in 2019 and ultimately led to …See details»

TARIS Biomedical LLC | Insights

Oct 8, 2024 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»

TARIS Biomedical® Launches Second Phase 1b Clinical Trial of …

Business Wire: August 10, 2016 – LEXINGTON, MA, U.S.A. – TARIS Biomedical, a company developing powerful and targeted new treatments for millions of patients suffering from difficult …See details»

linkstock.net © 2022. All rights reserved